Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

A Phase 1b, Open-label, Multiple-Dose Study Evaluating Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Pociredir in Patients With Sickle Cell Disease (SCD): Trial Design

2025Journal of sickle cell disease.JournalOpen access

10.1093/jscdis/yoaf013.001 Full text0 citations

Authors

15 authors across 10 institutions in 5 countries.

Sheinei AlanFirst author
Sheinei AlanFirst author
Sheinei AlanFirst author
Johhny Mahlangu
- University of the Witwatersrand (ZA)
as printed: Johnny Mahlangu
Michael Birrer
Foluke A. Fasola
- University College Hospital, Ibadan (NG)
- University of Ibadan (NG)
as printed: Foluke Fasola
Blessing Ojika
- National Hospital Abuja (NG)
Livingstone G. Dogara
- Kaduna State University (NG)
as printed: Livingstone Dogara
Kenneth Rivlin
Christy M Copeland
Christy M Copeland
Christy M Copeland
Rita Lemming
Thomas Winkler
Caterina MinnitiSenior author

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Hemoglobinopathies and Related Disorderslevel 3 · 1.00
Drug Transport and Resistance Mechanismslevel 3 · 0.95
PARP inhibition in cancer therapylevel 3 · 0.94

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2025 · Journal of sickle cell disease. · 0 citations
https://openalex.org/W4411101652

A Phase 1b, Open-label, Multiple-Dose Study Evaluating Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Pociredir in Patients With Sickle Cell Disease (SCD): Trial Design · Sankore